v3.26.1
Stock-based Compensation (Tables)
12 Months Ended
Jan. 31, 2026
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock-Based Compensation Expense

The following table summarizes stock-based compensation expense recognized related to awards granted to employees and nonemployees, as follows:

 

 

Year Ended
January 31,

 

(in thousands)

 

2026

 

 

2025

 

 

2024

 

Cost of revenue

 

$

7,227

 

 

$

4,028

 

 

$

3,909

 

Research and development

 

 

21,660

 

 

 

18,403

 

 

 

25,889

 

Sales and marketing

 

 

8,015

 

 

 

8,736

 

 

 

10,220

 

General and administrative

 

 

20,698

 

 

 

19,657

 

 

 

19,458

 

Total expense

 

 

57,600

 

 

 

50,824

 

 

 

59,476

 

Capitalized to internal-use software development costs and
   property and equipment

 

 

(2,605

)

 

 

(2,339

)

 

 

(2,344

)

Total stock-based compensation expense

 

$

54,995

 

 

$

48,485

 

 

$

57,132

 

Schedule of Stock Option Activity

A summary of stock option activity is as follows:

 

 

Options Outstanding

 

 

Number of
Options

 

 

Weighted
Average
Exercise
Price

 

 

Weighted
Average
Remaining
Term (Years)

 

 

Aggregate
Intrinsic
Value
(in thousands)

 

Balances at January 31, 2023

 

 

33,721,774

 

 

$

5.08

 

 

 

6.3

 

 

 

 

Exercised

 

 

(3,133,394

)

 

 

2.36

 

 

 

 

 

 

 

Forfeited

 

 

(3,631,427

)

 

 

5.48

 

 

 

 

 

 

 

Balances at January 31, 2024

 

 

26,956,953

 

 

 

5.34

 

 

 

5.7

 

 

 

 

Exercised

 

 

(1,956,382

)

 

 

2.95

 

 

 

 

 

 

 

Forfeited

 

 

(1,845,481

)

 

 

5.99

 

 

 

 

 

 

 

Balances at January 31, 2025

 

 

23,155,090

 

 

 

5.49

 

 

 

4.9

 

 

 

 

Exercised

 

 

(6,647,486

)

 

 

3.96

 

 

 

 

 

 

 

Forfeited

 

 

(1,974,901

)

 

 

9.19

 

 

 

 

 

 

 

Balances at January 31, 2026

 

 

14,532,703

 

 

$

5.69

 

 

 

4.4

 

 

$

280,184

 

Vested and exercisable at January 31, 2026

 

 

14,344,424

 

 

$

5.64

 

 

 

4.4

 

 

$

277,319

 

Schedule of Stock Options Outstanding and Exercisable by Price

A summary of options outstanding and exercisable by price at January 31, 2026 are as follows:

 

 

Options Outstanding

 

Options Exercisable

Weighted Average Exercise Price

 

Number of
Options

 

Weighted
Average
Remaining
Contractual
Life (in Years)

 

Number of
Options

 

Weighted
Average
Remaining
Contractual
Life (in Years)

$2.33

 

170,597

 

0.3

 

170,597

 

0.3

$3.69

 

310,296

 

1.5

 

310,296

 

1.5

$3.82

 

73,711

 

2.5

 

73,711

 

2.5

$3.92

 

2,471,008

 

3.5

 

2,471,008

 

3.5

$4.04

 

6,624,993

 

4.3

 

6,624,993

 

4.3

$5.25

 

710,725

 

5.0

 

710,725

 

5.0

$9.75

 

4,171,373

 

5.4

 

3,983,094

 

5.4

 

14,532,703

 

 

 

14,344,424

 

 

Schedule of Restricted Stock Unit ("RSU") Activity

A summary of RSU activity is as follows:

 

 

Number of
RSUs

 

 

Weighted
Average
Grant Date
Fair Value

 

Balances at January 31, 2023

 

 

16,972,601

 

 

$

5.90

 

Vested

 

 

(8,238,335

)

 

 

5.33

 

Granted

 

 

22,941,871

 

 

 

3.79

 

Forfeited

 

 

(4,957,371

)

 

 

4.91

 

Balances at January 31, 2024

 

 

26,718,766

 

 

$

4.45

 

Vested

 

 

(12,841,811

)

 

 

3.92

 

Granted

 

 

27,021,313

 

 

 

2.37

 

Forfeited

 

 

(8,289,041

)

 

 

3.66

 

Balances at January 31, 2025

 

 

32,609,227

 

 

$

3.14

 

Vested

 

 

(15,137,256

)

 

 

3.46

 

Granted

 

 

13,620,262

 

 

 

4.77

 

Forfeited

 

 

(2,578,272

)

 

 

3.29

 

Balances at January 31, 2026

 

 

28,513,961

 

 

$

3.73